Citizen Health, a provider of a digital health data management platform that helps patients collect, organize, securely store, and share their medical records with researchers for rare disease studies and research, raised $14.5 million in seed funding.
Transformation Capital led the funding round with participation from Wavemaker 360 and notable undisclosed angel investors.
With fresh funds, Citizen Health intends to further scale up its AI-enabled precision medicine therapies and care options to address a broader range of rare diseases. According to the National Institutes of Health, there are almost 10,000 rare diseases affecting 30 million Americans; and the rare diseases carry a U.S. economic burden of nearly $1 trillion annually.
In the official press statement, Farid Vij, CEO and co-founder of Citizen Health, stated: “With our collective experience and expertise, we’re working together to drive a future where any patient, at any stage, of any condition, has immediate access to exceptional guidance on the best action to take.”
“Through our AI-powered platform, we are giving people agency over their health data to help themselves and each other, while shaving years off the drug development process for these critical diseases,” added Farid Vij.